Actively Recruiting
Smart Measurement of Circulating Tumor DNA
Led by Erasmus Medical Center · Updated on 2025-08-11
50
Participants Needed
2
Research Sites
89 weeks
Total Duration
On this page
Sponsors
E
Erasmus Medical Center
Lead Sponsor
D
Dutch Cancer Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to develop a blood-test which can detect colorectal cancer in early stages. Participants will be asked to take an extra blood test, which will be analyzed further in the lab.
CONDITIONS
Official Title
Smart Measurement of Circulating Tumor DNA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Proven Lynch Syndrome (MMR-gene or EPCAM mutation) or a tumor with high microsatellite instability
- At least 18 years old
- Diagnosed with any form of cancer and not yet treated
- Provided informed consent to participate in the study
You will not qualify if you...
- Unwilling to undergo extra blood sampling
- Under 18 years old
- No newly diagnosed tumors at time of inclusion
- Have already been treated for their tumor
- Unable to read or understand Dutch or mentally incapable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333ZG
Not Yet Recruiting
2
Erasmus MC
Rotterdam, South Holland, Netherlands, 3015GD
Actively Recruiting
Research Team
L
Lotte van Leeuwen, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here